IntraMed - Artículos - Shock circulatorio
Una revisión actualizada e imprescindible | 11 NOV 13
Shock circulatorio
El shock circulatorio es un trastorno con alta morbimortalidad. Su rápida identificación es esencial para poder comenzar el tratamiento intensivo.
Autor: Dres. Vincent J-L, De Backer D N Engl J Med 2013;369:1726-34.
INDICE:  1.  | 2. Referencia
Referencia

1. Sakr Y, Reinhart K, Vincent JL, et al. Does dopamine administration in shock influence outcome? Results of the Sepsis Occurrence in Acutely Ill Patients (SOAP) Study. Crit Care Med 2006; 34:589-97.
2. Vincent JL, Ince C, Bakker J. Circulatory shock — an update: a tribute to Professor Max Harry Weil. Crit Care 2012; 16:239.
3. Weil MH, Shubin H. Proposed reclassification of shock states with special reference to distributive defects. Adv Exp Med Biol 1971; 23:13-23.
4. De Backer D, Biston P, Devriendt J, et al. Comparison of dopamine and norepinephrine in the treatment of shock. N Engl J Med 2010; 362:779-89.
5. Labovitz AJ, Noble VE, Bierig M, et al. Focused cardiac ultrasound in the emergent setting: a consensus statement of the American Society of Echocardiography and American College of Emergency Physicians. J Am Soc Echocardiogr 2010;23:1225-30.
6. Vincent JL, Rhodes A, Perel A, et al. Clinical review: update on hemodynamic monitoring — a consensus of 16. Crit Care 2011; 15:229.
7. Weil MH, Shubin H. The “VIP” approach to the bedside management of shock. JAMA 1969; 207:337-40.
8. Marik PE, Cavallazzi R, Vasu T, Hirani A. Dynamic changes in arterial waveform derived variables and fluid responsiveness in mechanically ventilated patients: a systematic review of the literature. Crit Care Med 2009; 37:2642-7.
9. Cavallaro F, Sandroni C, Marano C, et al. Diagnostic accuracy of passive leg raising for prediction of fluid responsiveness in adults: systematic review and metaanalysis of clinical studies. Intensive Care Med 2010; 36:1475-83.
10. Vincent JL, Weil MH. Fluid challenge revisited. Crit Care Med 2006; 34:1333-7.
11. Delaney AP, Dan A, McCaffrey J, Finfer S. The role of albumin as a resuscitation fluid for patients with sepsis: a systematic review and meta-analysis. Crit Care Med 2011; 39:386-91.
12. Myburgh JA, Mythen MG. Resuscitation fluids. N Engl J Med 2013; 369:1243-51.
13. Dellinger RP, Levy MM, Rhodes A, et al. Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2012. Crit Care Med 2013; 41:580-637.
14. Bellomo R, Chapman M, Finfer S, Hickling K, Myburgh J. Low-dose dopamine in patients with early renal dysfunction: a placebo-controlled randomised trial. Lancet 2000; 356:2139-43.
15. De Backer D, Aldecoa C, Njimi H, Vincent JL. Dopamine versus norepinephrine in the treatment of septic shock: a metaanalysis. Crit Care Med 2012; 40:725-30.
16. Levy B, Perez P, Perny J, Thivilier C, Gerard A. Comparison of norepinephrine –dobutamine to epinephrine for hemodynamics, lactate metabolism, and organ function variables in cardiogenic shock: a prospective, randomized pilot study. Crit Care Med 2011; 39:450-5.
17. Annane D, Vignon P, Renault A, et al. Norepinephrine plus dobutamine versus epinephrine alone for management of septic shock: a randomised trial. Lancet 2007; 370:676-84. [Erratum, Lancet 2007; 370:1034.]
18. Myburgh JA, Higgins A, Jovanovska A, Lipman J, Ramakrishnan N, Santamaria J. A comparison of epinephrine and norepinephrine in critically ill patients. Intensive Care Med 2008; 34:2226-34.
19. Alexander JH, Reynolds HR, Stebbins AL, et al. Effect of tilarginine acetate in patients with acute myocardial infarction and cardiogenic shock: the TRIUMPH randomized controlled trial. JAMA 2007; 297: 1657-66.
20. López A, Lorente JA, Steingrub J, et al. Multiple-center, randomized, placebo controlled, double-blind study of the nitric oxide synthase inhibitor 546C88: effect on survival in patients with septic shock. Crit Care Med 2004; 32:21-30.
21. Russell JA, Walley KR, Singer J, et al. Vasopressin versus norepinephrine infusion in patients with septic shock. N Engl J Med 2008; 358:877-87.
22. Russell JA, Walley KR, Gordon AC, et al. Interaction of vasopressin infusion, corticosteroid treatment, and mortality of septic shock. Crit Care Med 2009; 37:811-8.
23. De Backer D, Creteur J, Dubois MJ, et al. The effects of dobutamine on microcirculatory alterations in patients with septic shock are independent of its systemic effects. Crit Care Med 2006; 34: 403-8.
24. Jansen TC, van Bommel J, Schoonderbeek FJ, et al. Early lactate-guided therapy in intensive care unit patients: a multicenter, open-label, randomized controlled trial. Am J Respir Crit Care Med 2010; 182:752-61.
25. Thiele H, Zeymer U, Neumann FJ, et al. Intraaortic balloon support for myocardial infarction with cardiogenic shock. N Engl J Med 2012; 367:1287-96.
26. Combes A, Leprince P, Luyt CE, et al. Outcomes and long-term quality-of-life of patients supported by extracorporeal membrane oxygenation for refractory cardiogenic shock. Crit Care Med 2008; 36: 1404-11.
27. Vincent JL. Understanding cardiac output. Crit Care 2008; 12:174.
28. Rivers E, Nguyen B, Havstad S, et al. Early goal-directed therapy in the treatment of severe sepsis and septic shock. N Engl J Med 2001; 345:1368-77.
29. Vincent JL, Dufaye P, Berré J, Leeman M, Degaute JP, Kahn RJ. Serial lactate determinations during circulatory shock. Crit Care Med 1983; 11:449-51.
30. De Backer D, Hollenberg S, Boerma C, et al. How to evaluate the microcirculation: report of a round table conference. Crit Care 2007; 11:R101.
31. Sakr Y, Dubois MJ, De Backer D, Creteur J, Vincent JL. Persistent microcirculatory alterations are associated with organ failure and death in patients with septic shock. Crit Care Med 2004; 32:1825-31.
32. Gómez H, Torres A, Polanco P, et al. Use of non-invasive NIRS during a vascular occlusion test to assess dynamic tissue O(2) saturation response. Intensive Care Med 2008; 34:1600-7.
33. Creteur J, Carollo T, Soldati G, Buchele G, De Backer D, Vincent JL. The prognostic value of muscle StO2 in septic patients. Intensive Care Med 2007; 33:1549-56.
34. Rivers EP, Kruse JA, Jacobsen G, et al. The influence of early hemodynamic optimization on biomarker patterns of severe sepsis and septic shock. Crit Care Med 2007; 35:2016-24.
35. Corrêa TD, Vuda M, Blaser AR, et al. Effect of treatment delay on disease severity and need for resuscitation in porcine fecal peritonitis. Crit Care Med 2012; 40: 2841-9.

Comentarios

Usted debe estar registrado para expresar su opinión. Si ya es usuario de IntraMed o desea registrase como nuevo usuario, ingrese aquí
Dr. Javier Cabrera Reyes   Hace 9 meses
excelente articulo, muy organizado y exclarecedor, apoyado en estudios vasados en evidencia. muchas gracias
Dr. jhonny quiñones   Hace 10 meses
excelente articulo, muy didactico y ordenado, gracias
Dr. Ruben Tomas Moro Rodriguez   Hace 11 meses
excelente articulo
muy conciso y util para clasificar y ordenar conocimientos
gracias
Enf. Ma Elena Castillo Zapatero   Hace 11 meses
Excelente artículo. Gracias por actualizarnos
Dr. Roberto Solano Rodriguez   Hace 11 meses
Excelente, trabajo. Y de suma importancia el mantenernos actualizados, en el manejo de una patología tan compleja.
Dr. Luis Alberto Candales Arafet   Hace 11 meses
Excelente trabajo y sobre todo muy actualizado en referencia a la controversia entre el uso de Dopamina/Norepinefrina en el shock circulatorio. Gracias por esta nueva entrega
Ing. Bárbara Alcione Solar Sauri   Hace 11 meses
DIAMYL RDGUEZ MARTIN, 42 AÑOS DE EDAD, PRUEBA LARGA PARA VER SI LLEGA BESOSSS...
Dr. César Antonio Infante Gonzales   Hace 11 meses
Muy buen tema, felicidades...
Los más...
Términos y condiciones de uso | Todos los derechos reservados | Copyright 1997-2014